Dupilumab combined with a short-term narrowband-ultraviolet B phototherapy in a pediatric case of severe atopic dermatitis Şiddetli atopik dermatitli pediatrik hastada dupilumab ve dar bant ultraviyole B fototerapi kombinasyonu
Turkderm Turkish Archives of Dermatology and Venereology, cilt.56, sa.1, ss.39-41, 2022 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 56 Sayı: 1
- Basım Tarihi: 2022
- Doi Numarası: 10.4274/turkderm.galenos.2021.67424
- Dergi Adı: Turkderm Turkish Archives of Dermatology and Venereology
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.39-41
- Anahtar Kelimeler: Atopic dermatitis, dupilumab, narrowband UVB
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
Recently, dupilumab treatment in atopic dermatitis (AD) has been an effective and safe option in terms of adverse effects. However, combination therapies can sometimes be better at increasing efficacy or reducing adverse effects or cumulative doses. Early combination therapies may be more rational, especially considering that dupilumab treatment alone is less effective and has a late-onset efficacy. Here, we discussed dupilumab and a short-term narrowband ultraviolet B combination therapy in a child with AD.